icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research icrowd research

Generic Pharmaceuticals Market Projected to Exceed USD 766.50 Billion By 2032 With a 8.80 % CAGR | MRFR

Nov 9, 2023 7:00 PM ET

Generic Pharmaceuticals Market Projected to Exceed USD 766.50 Billion By 2032 With a 8.80 % CAGR | MRFR

Generic Pharmaceuticals Market Research Report: Information By Type (Simple Generics, Specialty Generics, and Biosimilars), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones and Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, and Others), By Product (Small Molecule and Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, and Others), By Distribution Channel, (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies) And By Region (Europe, Asia-Pacific, North America, And Rest Of The World) – Market Forecast Till 2032

According to MRFR analysis, the Generic Pharmaceuticals Market is expected to register a CAGR of 8.80 % from 2023 to 2032 and hold a value of over USD 766.50 Billion by 2032.

The global pharmaceutical industry has witnessed an impressive surge in the production and consumption of generic drugs. The generic pharmaceuticals market refers to drugs that are bioequivalent to brand-name drugs in terms of dosage, safety, strength, quality, performance, and intended use. As patents on brand-name drugs expire, it creates opportunities for generic pharmaceutical manufacturers to produce cost-effective alternatives.

Get Free Sample PDF Brochure @

Robotic process automation AI is the use of computational tools to carry out regular, rule-based processes, and this fact is driving the compound annual growth rate (CAGR) of the generic drugs market. The end result of this automation is that key operational players in the target market have more time, energy, and resources to allocate to higher-value operations. One of the most encouraging recent advances in the generic brand industry is the use of robotic process automation (RPA) to ensure compliance with standards and laws. The affordable nature of generic drugs contributes to greater access to healthcare and lowers total expenses. Factors such as rapid urbanization and digitalization, enhanced healthcare infrastructure, and increasing levels of awareness may boost market expansion.



The market segmentation of life science analytics, based on the type of analytics, The Generic Pharmaceuticals Market segmentation, based on type, includes simple generics, specialty generics, and biosimilars.

The Generic Pharmaceuticals Market segmentation, based on application, includes central nervous system disorders, respiratory diseases, hormones & related diseases, gastrointestinal diseases, cardiovascular diseases, infectious diseases, cancer, diabetes, and others. 

The Generic Pharmaceuticals Market segmentation, based on product, includes small molecules and large molecules.

The Generic Pharmaceuticals Market segmentation, based on the route of administration, includes oral, injectable, inhalable, and others. 

The Generic Pharmaceuticals Market segmentation, based on distribution channels, includes online pharmacies, retail pharmacies, and hospital pharmacies.

Key Players

Some of the key market players are: Teva Pharmaceutical Industries Ltd., Viatris Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., LUPIN, AbbVie Inc. (Allergan), AstraZeneca; Sawai Pharmaceutical Co.Ltd.; Hikma Pharmaceuticals PLC,  Dr. Reddy’s Laboratories Ltd., Cipla Inc.,  Sanofi, Aurobindo Pharma, and Endo International plc.

Regional Analysis

Due to a combination of factors including a developed healthcare system, an aging population, and widespread access to health information, the North American generic medicines industry is expected to lead the world.

Browse In-depth Market Research Report (132 Pages) on Generic Pharmaceuticals:

Because of factors such as the growing potential of cancer cell research and the increasing consumer awareness of medical technology advancements, the European generic pharmaceuticals market is the second largest in the world. Additionally, the German generic medicines industry maintained the highest proportion of the market, while the British generic pharmaceuticals market grew at the quickest rate in Europe.

From 2023 to 2032, the generic medicines market in Asia-Pacific is expected to expand at the fastest rate. This is because to the proliferation of government initiatives and the enhancement of medical infrastructure. The aging of the region’s population and the ensuing rise in public concern about health both play a role. A variety of government measures have contributed significantly to the rapid growth of the region’s generic medicines industry in recent years.

Discover More Research Reports on Healthcare Industry by Market Research Future:

Human Insulin Market Research Report Information By Fusion Type (Analogue Insulin, Traditional Human Insulin, Posterior Fusion), By Type (Metal, Polymer, And Others), By Diabetes Type (Diabetes 1, And Diabetes 2), By Distribution Channels (Hospital Pharmacy, Retail & Online Pharmacy, Neurology Clinics, And Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.

Obstructive Lung Disease Market Research Report– By Disease Type (Asthma, Bronchitis, Copd), By Product Type (Inhalers, Nebulizers), Drug Class (Combination Drug, Lta, Ics, Saba, Laba), Route of Administration, End User- Forecast till 2030

Chronic Kidney Disease Market Research Report Information by Diagnosis (Blood Test, Urine Test, Imaging Test, and Kidney Biopsy), by Treatment (Drugs, Dialysis, and Kidney Transplant) , by Indication (Type 1 Or Type 2 Diabetes, High Blood Pressure, and Polycystic Kidney Disease), by End User (Hospital & Clinics and Diagnostic Centers), by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Forecast till 2030

Membranous Nephropathy Market Research Report Information By Product Type (Primary and Secondary), By Type (Conservative Therapy, Non-immunosuppressive Therapy, and Immunosuppressive Therapy), By Material Type (Urine Test (Urinalysis), Blood Test, Glomerular Filtration Rate Test, and Antinuclear Antibody Test), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.

Cervical Cancer Treatment Market Research Report: Information By Type (Squamous Cell Carcinomas, Adenocarcinomas, and Adenosquamous Carcinomas), By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy), By End-User (Cancer Care Centers, Pharmacies, And Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

Tags: , , ,

See Campaign:

Contact Information:

Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: [email protected] Website:


Research Newswire, English